Literature DB >> 23050948

Tissue-specific interferon alpha subtype response to SIV infection in brain, spleen, and lung.

Luna Alammar Zaritsky1, Alicia Dery, Wan Yee Leong, Lucio Gama, Janice E Clements.   

Abstract

Interferon alpha (IFNalpha) is a type I interferon that plays a major role in host defense. There are 13 different IFNalpha genes in humans, but much of the work concerning their role in viral defense has been limited to studying either subtype 2 or pan IFNalpha due to the inability to distinguish between highly similar genetic and amino acid sequences. Because of recent advances in molecular and biochemical techniques, it is possible to study the regulation of individual subtypes. It has been reported that HIV/SIV infection results in impaired IFNalpha responses in certain tissues. Using a pigtailed macaque SIV model, we examined the subtype response during acute infection in 3 tissues that are known to be infected with HIV/SIV, but whose IFNalpha subtype response has not been extensively studied: the brain, spleen, and lung. We found that the expression and regulation of specific subtypes occur in a tissue-specific manner. There was more limited IFNalpha subtype expression in the lung and brain, where predominantly macrophages are infected compared to the spleen, which contains both infected CD4+ lymphocytes and macrophages. Understanding the IFNalpha subtype response in tissues known to be infected with HIV/SIV can help tailor adjunctive treatment regimens to highly active antiretroviral therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23050948      PMCID: PMC3539257          DOI: 10.1089/jir.2012.0018

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  44 in total

Review 1.  Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review.

Authors:  E Dieperink; M Willenbring; S B Ho
Journal:  Am J Psychiatry       Date:  2000-06       Impact factor: 18.112

Review 2.  Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors.

Authors:  Kenya Honda; Akinori Takaoka; Tadatsugu Taniguchi
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

3.  Relative transcriptional inducibility of the human interferon-alpha subtypes conferred by the virus-responsive enhancer sequence.

Authors:  C L Dent; S J Macbride; N A Sharp; D R Gewert
Journal:  J Interferon Cytokine Res       Date:  1996-02       Impact factor: 2.607

4.  Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS).

Authors:  C R Newton; A Graham; L E Heptinstall; S J Powell; C Summers; N Kalsheker; J C Smith; A F Markham
Journal:  Nucleic Acids Res       Date:  1989-04-11       Impact factor: 16.971

5.  Interferon alfa subtypes and levels of type I interferons in the liver and peripheral mononuclear cells in patients with chronic hepatitis C and controls.

Authors:  Y Castelruiz; E Larrea; P Boya; M P Civeira; J Prieto
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

6.  Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration.

Authors:  Y Akwa; D E Hassett; M L Eloranta; K Sandberg; E Masliah; H Powell; J L Whitton; F E Bloom; I L Campbell
Journal:  J Immunol       Date:  1998-11-01       Impact factor: 5.422

7.  Anti-rhinoviral activity of recombinant and hybrid species of interferon alpha.

Authors:  S J Sperber; S B Hunger; B Schwartz; S Pestka
Journal:  Antiviral Res       Date:  1993-10       Impact factor: 5.970

8.  Primary infection with simian immunodeficiency virus: plasmacytoid dendritic cell homing to lymph nodes, type I interferon, and immune suppression.

Authors:  Benoît Malleret; Benjamin Manéglier; Ingrid Karlsson; Pierre Lebon; Michelina Nascimbeni; Leïla Perié; Patricia Brochard; Benoît Delache; Julien Calvo; Thibault Andrieu; Odile Spreux-Varoquaux; Anne Hosmalin; Roger Le Grand; Bruno Vaslin
Journal:  Blood       Date:  2008-09-11       Impact factor: 22.113

9.  Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS.

Authors:  Eleanor S Roberts; Michelle A Zandonatti; Debbie D Watry; Lisa J Madden; Steven J Henriksen; Michael A Taffe; Howard S Fox
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

10.  Mechanism for the establishment of transcriptional HIV latency in the brain in a simian immunodeficiency virus-macaque model.

Authors:  Sheila A Barber; Lucio Gama; Justyna M Dudaronek; Tauni Voelker; Patrick M Tarwater; Janice E Clements
Journal:  J Infect Dis       Date:  2006-02-21       Impact factor: 5.226

View more
  12 in total

1.  CCR2 Signaling Selectively Regulates IFN-α: Role of β-Arrestin 2 in IFNAR1 Internalization.

Authors:  Dionna W Williams; Lauren C Askew; Elonna Jones; Janice E Clements
Journal:  J Immunol       Date:  2018-11-30       Impact factor: 5.422

2.  Splenic Damage during SIV Infection: Role of T-Cell Depletion and Macrophage Polarization and Infection.

Authors:  Dionna W Williams; Elizabeth L Engle; Erin N Shirk; Suzanne E Queen; Lucio Gama; Joseph L Mankowski; M Christine Zink; Janice E Clements
Journal:  Am J Pathol       Date:  2016-06-18       Impact factor: 4.307

Review 3.  Interferons and viruses: an evolutionary arms race of molecular interactions.

Authors:  Hans-Heinrich Hoffmann; William M Schneider; Charles M Rice
Journal:  Trends Immunol       Date:  2015-02-20       Impact factor: 16.687

4.  Macrophages sustain HIV replication in vivo independently of T cells.

Authors:  Jenna B Honeycutt; Angela Wahl; Caroline Baker; Rae Ann Spagnuolo; John Foster; Oksana Zakharova; Stephen Wietgrefe; Carolina Caro-Vegas; Victoria Madden; Garrett Sharpe; Ashley T Haase; Joseph J Eron; J Victor Garcia
Journal:  J Clin Invest       Date:  2016-03-07       Impact factor: 14.808

5.  A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis.

Authors:  Stephanie M Dillon; Kejun Guo; Gregory L Austin; Sara Gianella; Phillip A Engen; Ece A Mutlu; John Losurdo; Garth Swanson; Prachi Chakradeo; Ali Keshavarzian; Alan L Landay; Mario L Santiago; Cara C Wilson
Journal:  AIDS       Date:  2018-07-31       Impact factor: 4.177

Review 6.  HIV life cycle, innate immunity and autophagy in the central nervous system.

Authors:  Kelly A Meulendyke; Joshua D Croteau; M Christine Zink
Journal:  Curr Opin HIV AIDS       Date:  2014-11       Impact factor: 4.283

Review 7.  Interferon-α Subtypes As an Adjunct Therapeutic Approach for Human Immunodeficiency Virus Functional Cure.

Authors:  Jeffy George; Joseph J Mattapallil
Journal:  Front Immunol       Date:  2018-02-22       Impact factor: 7.561

Review 8.  Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome.

Authors:  Carolina Scagnolari; Guido Antonelli
Journal:  Cytokine Growth Factor Rev       Date:  2018-03-16       Impact factor: 7.638

9.  Early detection of simian immunodeficiency virus in the central nervous system following oral administration to rhesus macaques.

Authors:  Jeffrey M Milush; Hui-Ling Chen; Ginger Atteberry; Donald L Sodora
Journal:  Front Immunol       Date:  2013-08-14       Impact factor: 7.561

Review 10.  The Cholinergic Anti-Inflammatory Response and the Role of Macrophages in HIV-Induced Inflammation.

Authors:  Manuel Delgado-Vélez; José A Lasalde-Dominicci
Journal:  Int J Mol Sci       Date:  2018-05-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.